These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Antibiotic resistance among clinically important gram-positive bacteria in the UK. Johnson AP J Hosp Infect; 1998 Sep; 40(1):17-26. PubMed ID: 9777517 [TBL] [Abstract][Full Text] [Related]
5. Colonisation and infection with resistant gram-positive cocci. Epidemiology and risk factors. Cars O Drugs; 1997; 54 Suppl 6():4-10. PubMed ID: 9474476 [TBL] [Abstract][Full Text] [Related]
6. Natural history of colonization with vancomycin-resistant enterococci, methicillin-resistant Staphylococcus aureus, and resistant gram-negative bacilli among long-term-care facility residents. Pacio GA; Visintainer P; Maguire G; Wormser GP; Raffalli J; Montecalvo MA Infect Control Hosp Epidemiol; 2003 Apr; 24(4):246-50. PubMed ID: 12725352 [TBL] [Abstract][Full Text] [Related]
7. Bacterial resistance to antimicrobial agents: an overview from Korea. Kim WJ; Park SC Yonsei Med J; 1998 Dec; 39(6):488-94. PubMed ID: 10097674 [TBL] [Abstract][Full Text] [Related]
8. Control of multiply resistant cocci: do international comparisons help? Harbarth S; Albrich W; Goldmann DA; Huebner J Lancet Infect Dis; 2001 Nov; 1(4):251-61. PubMed ID: 11871512 [TBL] [Abstract][Full Text] [Related]
9. [Linezolid in the treatment of antibiotic-resistant gram-positive infections of the musculoskeletal system]. Jahoda D; Nyc O; Pokorný D; Landor I; Sosna A Acta Chir Orthop Traumatol Cech; 2006 Oct; 73(5):329-33. PubMed ID: 17140514 [TBL] [Abstract][Full Text] [Related]
10. Linezolid. French G Int J Clin Pract; 2001; 55(1):59-63. PubMed ID: 11219321 [TBL] [Abstract][Full Text] [Related]
11. [Gram-positive bacterial infections resistant to antibiotic treatment]. Utili R Ann Ital Med Int; 2001; 16(4):205-19. PubMed ID: 11799629 [TBL] [Abstract][Full Text] [Related]
12. Mechanisms of β-lactam antimicrobial resistance and epidemiology of major community- and healthcare-associated multidrug-resistant bacteria. Tang SS; Apisarnthanarak A; Hsu LY Adv Drug Deliv Rev; 2014 Nov; 78():3-13. PubMed ID: 25134490 [TBL] [Abstract][Full Text] [Related]
13. Emerging issues in the diagnosis and management of infections caused by multi-drug-resistant, gram-positive cocci. Napolitano LM Surg Infect (Larchmt); 2005; 6 Suppl 2():S-5-22. PubMed ID: 23577494 [TBL] [Abstract][Full Text] [Related]
14. [Effectiveness and risks of isolation precautions in patients with MRSA and other multidrug-resistant bacteria]. Dettenkofer M; Utzolino S; Luft D; Lemmen S Zentralbl Chir; 2010 Apr; 135(2):124-8. PubMed ID: 20379942 [TBL] [Abstract][Full Text] [Related]
16. [Strategies for management of resistant Gram-positive infections: from S. pneumoniae to MRSA]. Cristini F Infez Med; 2007 Sep; 15 Suppl 2():13-9. PubMed ID: 17940408 [TBL] [Abstract][Full Text] [Related]